US Pharma MarketingThe post BioVie stock sinks on Phase IIb Parkinson’s trial data appeared first on Clinical Trials Arena.
BioVie stock sinks on Phase IIb Parkinson’s trial data
BioVie used an endpoint called EPNIC-15, which is not well known in Parkinson's and only appears to be referenced in papers by the company itself. The post BioVie stock sinks on Phase IIb Parkinson’s trial data appeared first on Clinical Trials Arena .
BioVie used an endpoint called EPNIC-15, which is not well known in Parkinson's and only appears to be referenced in papers by the company itself.
Source: Clinical Trials Arena